undamentalytics Newsletter

Medpace Holdings, Inc. number of employees

Medpace Holdings, Inc. reported 6,200 employees at December 31, 2025 in its latest annual report, up 300 (5.1%) on the year before. That compares with 4,500 at December 31, 2021. Revenue per employee was $408,102.

Headcount by year

Fiscal year endEmployeesChangeRevenue per employeeSource
December 31, 2025 6,200 +300 (5.1%) $408,102 10-K, filed February 10, 2026
December 31, 2024 5,900 +0 (0.0%) $357,467 10-K, filed February 11, 2025
December 31, 2023 5,900 +700 (13.5%) $319,634 10-K, filed February 13, 2024
December 31, 2022 5,200 +700 (15.6%) $280,768 10-K, filed February 14, 2023
December 31, 2021 4,500 — $253,862 10-K, filed February 15, 2022

What the annual reports say

  • Human Capital As of December 31, 2025 we had approximately 6,200 employees located across 46 countries. 2025 annual report
  • Human Capital As of December 31, 2024 we had approximately 5,900 employees located across 44 countries. 2024 annual report
  • Human Capital As of December 31, 2023 we had approximately 5,900 employees located across 42 countries. 2023 annual report
  • Human Capital As of December 31, 2022 we had approximately 5,200 employees located across 40 countries. 2022 annual report
  • Human Capital As of December 31, 2021 we had approximately 4,500 employees located across 41 countries. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BIO vs MEDPBRKR vs MEDP

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Medpace Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medpace Holdings, Inc.